Dyrenium (WellSpring Pharmaceutical Corporation)
Welcome to the PulseAid listing for the Dyrenium drug offered from WellSpring Pharmaceutical Corporation. This Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | WellSpring Pharmaceutical Corporation |
| NON-PROPRIETARY NAME: | Triamterene |
| SUBSTANCE NAME: | TRIAMTERENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-10-01 |
| END MARKETING DATE: | 2019-12-31 |
Dyrenium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dyrenium from WellSpring Pharmaceutical Corporation |
| LABELER NAME: | WellSpring Pharmaceutical Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1999-10-01 |
| END MARKETING DATE: | 2019-12-31 |
| PRODUCT ID: | 65197-002_96d12576-d968-41bc-ad64-fd3812e09f25 |
| PRODUCT NDC: | 65197-002 |
| APPLICATION NUMBER: | NDA013174 |
Other TRIAMTERENE Pharmaceutical Manufacturers / Labelers:
